Gsa Capital Partners LLP Neuro Pace Inc Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
A detailed history of Gsa Capital Partners LLP transactions in Neuro Pace Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 54,536 shares of NPCE stock, worth $700,242. This represents 0.05% of its overall portfolio holdings.
Number of Shares
54,536
Previous 53,213
2.49%
Holding current value
$700,242
Previous $593,000
5.23%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
84Shares Held
24.6MCall Options Held
20.2KPut Options Held
21.9K-
Polar Capital Holdings PLC London, X03.1MShares$39.8 Million0.17% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$38 Million1.88% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.61MShares$33.6 Million0.93% of portfolio
-
Morgan Stanley New York, NY2.55MShares$32.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$18.4 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $319M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...